$1.86
Value $258M
CYH and MRK stock compared: price, dividend, valuation and results, from SEC filings.
$1.86
Value $258M
$137.78
Value $341B
Community Health Systems (CYH) has a market value of $258M and Merck & Company (MRK) $341B. Over the last year, with dividends, CYH moved -38.2% and MRK +52.7%. The P/E is 7.2 for CYH and 138.9 for MRK. Dividend yield: CYH none, MRK 2.47%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CYH$258M
MRK$341B
MRK is 1,321 times CYH
Revenue, 12 months
CYH$11.7B
MRK$67.4B
MRK is 5.8 times CYH
Net income, 12 months
CYH$36M
MRK$2.5B
MRK is 68 times CYH
Operating margin
CYH10.9%
MRK–
ROIC
CYH11.6%
MRK3.9%
7.7 points apart
P/E
CYH7.2
MRK138.9
MRK is 19 times CYH
Dividend yield
CYH0.0%
MRK2.5%
2.5 points apart
5-year return
CYH-87.4%
MRK+94.3%
181.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CYH-87.4%
MRK+94.3%
| Period | CYHWith dividends | MRKWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | -38.2%Price -38.2% | +52.7%Price +48.4% |
| 3 years since November 17, 2023 | -33.6%-12.7% a yearPrice -33.6% | +48.4%+14.1% a yearPrice +35.4% |
| 5 years since November 17, 2021 | -87.4%-33.9% a yearPrice -87.4% | +94.3%+14.2% a yearPrice +66.8% |
| 10 years since November 18, 2016 | -67.8%-10.7% a yearPrice -67.8% | +216.6%+12.2% a yearPrice +133.4% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CYHCommunity Health SystemsMRKMerck & Company
| Price | $1.86 | $137.78 |
|---|---|---|
| Market value | $258M | $341B |
| Enterprise value (EV) | $9.7B | $385B |
| P/E | 7.2 | 138.9 |
| P/E, 5-year median | 7.6 | 14.8 |
| P/B | – | 7.6 |
| EV/EBIT | 7.7 | 80.8 |
| Free cash flow yield | – | 4.3% |
| Revenue, 12 months | $11.7B | $67.4B |
|---|---|---|
| Net income, 12 months | $36M | $2.5B |
| Free cash flow, 12 months | -$122M | $14.7B |
| Earnings per share, 12 months | $0.25 | $0.98 |
| Revenue growth, year on year | -1.2% | 1.3% |
| Revenue growth a year, past | +1.2%over 5 years | +9.4%over 5 years |
| EPS growth a year, past | -3.0%over 5 years | +21.2%over 5 years |
| Gross margin | 85.5% | 71.8% |
|---|---|---|
| Operating margin | 10.9% | – |
| Net margin | 0.3% | 3.6% |
| ROIC | 11.6% | 3.9% |
| ROE | – | 5.2% |
| Cash | $155M | $9.7B |
|---|---|---|
| Total debt | $10.2B | $53.8B |
| Net debt / EBITDA | 5.6 | 5.7 |
| Interest cover | – | 2.4× |
| Dividend yield | – | 2.5% |
|---|---|---|
| Dividend per share, 12 months | – | $3.40 |
| Dividend growth a year, past | – | +5.8%over 5 years |
| Buyback yield | – | 1.5% |
| Shareholder yield | – | 4.0% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Merck & Company ($341B) is about 1,321.1 times Community Health Systems ($258M), at today's prices.
Since November 18, 2016, CYH's price moved -67.8% and MRK's +133.4%. With dividends: CYH -67.8% (-10.7% a year), MRK +216.6% (+12.2% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Community Health Systems and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.
At today's price, the P/E is 7.2 for CYH and 138.9 for MRK. The median of the last five years was 7.6 and 14.8, which shows where each stands against its own past.
Over the last twelve months, the net margin was 0.3% for Community Health Systems and 3.6% for Merck & Company, and the operating margin 10.9% and –. Revenue was $11.7B and $67.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.